Brief history All three medications are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions.Carisoprodol, cyclobenzaprine and metaxalone are not found to be effective in the treatment of spasticity associated with upper motor neuron syndromes.CNS depression produces sedation, and the perception of pain could be altered.Some believe that most of the benefit seen with carisoprodol is secondary to a generalized sedative effect.Treato does not provide medical advice, diagnosis or treatment.
Cyclobenzaprine is contraindicated in patients with hyperthyroidism, congestive heart failure, and other heart conductions. Studies have indicated they may be more effective in combination with analgesics.
This review investigates the efficacy, side effects, and safety of three commonly prescribed skeletal muscle relaxants metaxalone (Skelaxin), cyclobenzaprine (Flexeril), and carisoprodol (Soma).
Muscle relaxants are not really a class of drugs, but rather a group of different medications that produce an overall sedative effect on the body.
Its mode of action may be due to general central nervous system depression.
All three drugs appear to have equal efficacy, but their side effects vary considerably.